Perspective Therapeutics (CATX) Cash from Operations (2016 - 2026)
Perspective Therapeutics' Cash from Operations history spans 17 years, with the latest figure at 31468000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations fell 45.81% to 31468000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 92370000.0, a 71.93% decrease, with the full-year FY2025 number at 82484000.0, down 350.88% from a year prior.
- Cash from Operations hit 31468000.0 in Q1 2026 for Perspective Therapeutics, down from 24657000.0 in the prior quarter.
- Over the last five years, Cash from Operations for CATX hit a ceiling of 13848000.0 in Q1 2024 and a floor of 31468000.0 in Q1 2026.
- Historically, Cash from Operations has averaged 10749823.53 across 5 years, with a median of 9008000.0 in 2023.
- Biggest five-year swings in Cash from Operations: soared 242.43% in 2024 and later crashed 584.02% in 2025.
- Tracing CATX's Cash from Operations over 5 years: stood at 6086000.0 in 2022, then plummeted by 48.01% to 9008000.0 in 2023, then crashed by 195.36% to 26606000.0 in 2024, then grew by 7.33% to 24657000.0 in 2025, then decreased by 27.62% to 31468000.0 in 2026.
- Business Quant data shows Cash from Operations for CATX at 31468000.0 in Q1 2026, 24657000.0 in Q4 2025, and 16292000.0 in Q3 2025.